Kellerhals Carrard with Pershing Medical on Ligamys scquisition
Kellerhals Carrard advised the Bern-based sports medicine start-up Pershing Medical in its acquisition of the Ligamys™ product line—a technology for the natural healing of the anterior cruciate ligament (ACL)—from the international medical technology group Enovis Corporation (NYSE: ENOV).
The company
Pershing Medical specialises in the development of advanced medical products for the sports sector. The company aims to improve the treatment of sports injuries through scientifically based solutions and to enable athletes to return to their activities more quickly.
The Kellerhals Carrard team
The Kellerhals Carrard team working on the matter included Thomas Bähler (pictured), Kathrin Enderli, Michèle Remund, Patrick Mettler, and Philippe Frésard.
